New cholesterol drug shows promise for seniors in 6-Month study
NCT ID NCT07489183
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well the drug atostazet lowers cholesterol and affects blood sugar in people aged 65 and older with high cholesterol. Over 600 participants took the drug for 6 months, and researchers tracked side effects and changes in glucose metabolism. The goal was to confirm the drug's safety and effectiveness in this older population.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- atostazet
- What this could lead to
- If successful, this could confirm atostazet as a safe and effective option for lowering cholesterol in older adults.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be less reliable. It only lasted 6 months, so long-term safety and benefits are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Building 1897
Seoul, 04516, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill tame high cholesterol?
- Ancient herbal mix put to the test against high cholesterol
- Cookies that could fight cholesterol: pumpkin seeds and walnuts put to the test
- Could a daily pill help kids with inherited high cholesterol?
- Free meds and tailored education may cut heart risks in Low-Income seniors
- Can a smartphone app help lower bad cholesterol?